Studies

Cardiologist Tested the Concoction of GIK for Reduction of Heart Attack Mortality Rate

By on
Concoction of Glucose, Insulin and Potassium (GIK) Potentially Reduce Heart Attack Mortality Rate

A recent study shows that GIK solution can reduce the mortality rate of a heart attack, which kills one person every minute.

GIK, a concoction of glucose, insulin, and potassium (K), is suggested to be a simple solution for heart attack, also known as acute myocardial infarction (AMI). While there are skepticisms for GIK, the possible reduction of the mortality rate for people having a heart attack should not be brushed off our shoulders.

GIK: A Solution For Heart Attack?

Myocardial Infarction or Heart Attack

Myocardial infarction is also known as heart attack. (Source: Wikimedia CC)

Estudio Cardiologico Latinoamerica (ECLA) conducted a study of AMI patients that were given a treatment of GIK solution. They had 264 participants for the study – 133 of them were given GIK, while 134 patients were given a placebo.

The results varied based on the dosage given. Patients given a low dose of GIK got a 28 percent decreased mortality rate during an AMI occurrence as compared to the placebo group.

Meanwhile, those with high dosage received a decreased mortality rate of 48 percent versus the study’s placebo group.

A separate study conducted by cardiologist Harry Selker also gave remarkable results.

Fifty percent was reduced in the mortality rate of patients that were administered with GIK. In the succeeding month, a 40 percent reduction rate continued to show great results.

Doubts For GIK Studies

GIK, however, receives controversies on its studies. Some of it includes flaws seen in the length of time for the infusion of the treatment and the heart attack occurrence. Others question the validity of the findings based on the participants of ECLA’s number and randomness.

But the possibility of GIK as a solution for heart attack is not new. In fact, 50 years ago, rabbits and baboons were tested as GIK showed signs of protecting the heart’s muscles against damage.

However, it did not reveal the same results to humans, leading the research to be shelved. That is why Selker looked into the reason behind the failure of the human trials.

Partnered with his own research, he was able to find out that administering GIK early, before even bringing the patient to the hospital, is what makes it more effective.

After Selker has done his work, he admitted, though, of contacting pharmaceutical companies to make it. But because of its affordability, no one was interested.

Further research on GIK, like the study conducted in ECLA, can soon prove that the cocktail of glucose, insulin and potassium can help in acute coronary emergencies and treat the restricted blood flow suffered by heart attack patients.

Photo source: Pixabay

About the author

To Top